Tower Research Capital (TRC)’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-140
Closed -$2K 6990
2021
Q3
$2K Sell
140
-1,589
-92% -$17.7K ﹤0.01% 5392
2021
Q2
$19K Buy
1,729
+1,487
+614% +$16.7K ﹤0.01% 3970
2021
Q1
$3K Sell
242
-3,629
-94% -$36.9K ﹤0.01% 4971
2020
Q4
$33K Buy
3,871
+1,153
+42% +$9.95K ﹤0.01% 3504
2020
Q3
$21K Buy
+2,718
New +$22.3K ﹤0.01% 3859
2020
Q1
Sell
-1,934
Closed -$19K 4275
2019
Q4
$19K Buy
+1,934
New +$19.7K ﹤0.01% 1971
2019
Q2
Sell
-72
Closed -$1K 4566
2019
Q1
$1K Buy
+72
New +$709 ﹤0.01% 3679

Other funds holding NFH

Tower Research Capital (TRC)'s NFH Position: Q4 2021 in Review

Tower Research Capital (TRC) sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q4 2021, closing a stake of 140 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in NFH in Q1 2019 and held it in 7 quarters. The position peaked at $33K in Q4 2020. 62 funds tracked by Wall St. Rank hold NFH as of Q4 2021.

  • Tower Research Capital (TRC) reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 140 New Frontier Health Corporation Ordinary Shares shares in Q4 2021, an estimated $2K.
  • Tower Research Capital (TRC) first reported a position in New Frontier Health Corporation Ordinary Shares in Q1 2019 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s New Frontier Health Corporation Ordinary Shares position peaked at $33K in Q4 2020.
  • 62 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q4 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.